238 related articles for article (PubMed ID: 28427528)
1. Mechanisms of chemotherapy-induced ovarian damage in breast cancer patients.
Codacci-Pisanelli G; Del Pup L; Del Grande M; Peccatori FA
Crit Rev Oncol Hematol; 2017 May; 113():90-96. PubMed ID: 28427528
[TBL] [Abstract][Full Text] [Related]
2. [Fertility preservation strategies in young women in case of breast cancer or hematologic malignancy].
Decanter C; Robin G
Gynecol Obstet Fertil; 2013 Oct; 41(10):597-600. PubMed ID: 24094596
[TBL] [Abstract][Full Text] [Related]
3. Conservative management of reproductive cancers. Ovarian protection during treatment.
Cui W; Phillips KA
Best Pract Res Clin Obstet Gynaecol; 2019 Feb; 55():49-58. PubMed ID: 30150091
[TBL] [Abstract][Full Text] [Related]
4. Advances in the Treatment and Prevention of Chemotherapy-Induced Ovarian Toxicity.
Cho HW; Lee S; Min KJ; Hong JH; Song JY; Lee JK; Lee NW; Kim T
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33096794
[TBL] [Abstract][Full Text] [Related]
5. [Oncofertility and breast cancer].
Sonigo C; Grynberg M; Bringer S; Sermondade N
Bull Cancer; 2019 Dec; 106(12S1):S43-S52. PubMed ID: 32008738
[TBL] [Abstract][Full Text] [Related]
6. Fertility after breast cancer treatment.
Kasum M; Beketić-Orešković L; Peddi PF; Orešković S; Johnson RH
Eur J Obstet Gynecol Reprod Biol; 2014 Feb; 173():13-8. PubMed ID: 24315568
[TBL] [Abstract][Full Text] [Related]
7. [Successful ovarian tissue transplantation in woman with premature ovarian failure after gonadotoxic treatment].
Mardešić T; Jelínková L; Melicharová L
Ceska Gynekol; 2017; 82(1):38-41. PubMed ID: 28252304
[TBL] [Abstract][Full Text] [Related]
8. Prospective study to optimize care and improve knowledge on ovarian function and/or fertility preservation in young breast cancer patients: Results of the pilot phase of the PREgnancy and FERtility (PREFER) study.
Lambertini M; Fontana V; Massarotti C; Poggio F; Dellepiane C; Iacono G; Abate A; Miglietta L; Ferreccio C; Pescio MC; Conte B; Blondeaux E; Bighin C; D'Alonzo A; Vaglica M; Zanardi E; Boccardo F; Ballestrero A; Anserini P; Del Mastro L
Breast; 2018 Oct; 41():51-56. PubMed ID: 30007268
[TBL] [Abstract][Full Text] [Related]
9. Ovarian damage from chemotherapy and current approaches to its protection.
Spears N; Lopes F; Stefansdottir A; Rossi V; De Felici M; Anderson RA; Klinger FG
Hum Reprod Update; 2019 Nov; 25(6):673-693. PubMed ID: 31600388
[TBL] [Abstract][Full Text] [Related]
10. Cryopreservation of in vitro matured oocytes in addition to ovarian tissue freezing for fertility preservation in paediatric female cancer patients before and after cancer therapy.
Abir R; Ben-Aharon I; Garor R; Yaniv I; Ash S; Stemmer SM; Ben-Haroush A; Freud E; Kravarusic D; Sapir O; Fisch B
Hum Reprod; 2016 Apr; 31(4):750-62. PubMed ID: 26848188
[TBL] [Abstract][Full Text] [Related]
11. Novel aspects on gonadotoxicity and fertility preservation in lymphoproliferative neoplasms.
Silvestris E; Cormio G; Skrypets T; Dellino M; Paradiso AV; Guarini A; Minoia C
Crit Rev Oncol Hematol; 2020 Jul; 151():102981. PubMed ID: 32485429
[TBL] [Abstract][Full Text] [Related]
12. Fertility preservation in breast cancer patients.
Rodgers RJ
Minerva Ginecol; 2019 Jun; 71(3):196-206. PubMed ID: 31089071
[TBL] [Abstract][Full Text] [Related]
13. Temporary ovarian suppression during chemotherapy to preserve ovarian function and fertility in breast cancer patients: A GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology.
Lambertini M; Cinquini M; Moschetti I; Peccatori FA; Anserini P; Valenzano Menada M; Tomirotti M; Del Mastro L
Eur J Cancer; 2017 Jan; 71():25-33. PubMed ID: 27940355
[TBL] [Abstract][Full Text] [Related]
14. THERAPY OF ENDOCRINE DISEASE: Novel protection and treatment strategies for chemotherapy-associated ovarian damage.
Xiong J; Xue L; Li Y; Tang W; Chen D; Zhang J; Dai J; Zhou S; Lu Z; Wu M; Wang S
Eur J Endocrinol; 2021 May; 184(5):R177-R192. PubMed ID: 33630753
[TBL] [Abstract][Full Text] [Related]
15. Preventing ovarian failure associated with chemotherapy.
Cui W; Stern C; Hickey M; Goldblatt F; Anazodo A; Stevenson WS; Phillips KA
Med J Aust; 2018 Nov; 209(9):412-416. PubMed ID: 30376664
[TBL] [Abstract][Full Text] [Related]
16. Ceramide-1-phosphate has protective properties against cyclophosphamide-induced ovarian damage in a mice model of premature ovarian failure.
Pascuali N; Scotti L; Di Pietro M; Oubiña G; Bas D; May M; Gómez Muñoz A; Cuasnicú PS; Cohen DJ; Tesone M; Abramovich D; Parborell F
Hum Reprod; 2018 May; 33(5):844-859. PubMed ID: 29534229
[TBL] [Abstract][Full Text] [Related]
17. Strategies for fertility preservation in young early breast cancer patients.
Tomasi-Cont N; Lambertini M; Hulsbosch S; Peccatori AF; Amant F
Breast; 2014 Oct; 23(5):503-10. PubMed ID: 24934638
[TBL] [Abstract][Full Text] [Related]
18. The Impact of Chemotherapy on the Ovaries: Molecular Aspects and the Prevention of Ovarian Damage.
Sonigo C; Beau I; Binart N; Grynberg M
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31717833
[TBL] [Abstract][Full Text] [Related]
19. [Fertility preservation in women of the childbearing age: Indications and strategies].
Bénard J; Calvo J; Comtet M; Benoit A; Sifer C; Grynberg M
J Gynecol Obstet Biol Reprod (Paris); 2016 May; 45(5):424-44. PubMed ID: 27021926
[TBL] [Abstract][Full Text] [Related]
20. Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in breast cancer patients.
Conte B; Del Mastro L
Minerva Ginecol; 2017 Aug; 69(4):350-356. PubMed ID: 28398024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
